CXCL8 and renal cell carcinoma: No statistically significant differences were observed considering the retrospective versus prospective design of the studies analyzed; however, the impact of IL-8 levels on advanced RCC appeared to be qualitatively more evident in retrospective studies, likely due to greater heterogeneity between studies in terms of patients’ populations and treatments in prospective trials.